1. Home
  2. ZJYL vs UNCY Comparison

ZJYL vs UNCY Comparison

Compare ZJYL & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JIN MEDICAL INTERNATIONAL LTD.

ZJYL

JIN MEDICAL INTERNATIONAL LTD.

HOLD

Current Price

$1.99

Market Cap

145.9M

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$4.81

Market Cap

150.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZJYL
UNCY
Founded
2006
2016
Country
China
United States
Employees
273
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
145.9M
150.1M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ZJYL
UNCY
Price
$1.99
$4.81
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$25.67
AVG Volume (30 Days)
38.9K
743.2K
Earning Date
08-20-2025
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$675,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$582.86
P/E Ratio
$18.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$3.72
52 Week High
$4.50
$8.74

Technical Indicators

Market Signals
Indicator
ZJYL
UNCY
Relative Strength Index (RSI) 38.64 38.41
Support Level $1.94 $3.93
Resistance Level $2.59 $5.86
Average True Range (ATR) 0.18 0.22
MACD -0.04 -0.04
Stochastic Oscillator 18.25 9.00

Price Performance

Historical Comparison
ZJYL
UNCY

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Share on Social Networks: